Dec 13 2024 18 mins
Visit https://www.peervoice.com/TBT860 to view the entire programme with slides. After completing “Srikala Sridhar, MD, MSc, FRCPC - Transforming Care With Immunotherapy Combinations in the First-Line Treatment of Advanced or Metastatic Urothelial Carcinoma”, participants will be able to: Discuss the latest evidence with immunotherapy-based combinations in the first-line treatment of locally advanced or metastatic urothelial carcinoma (UC); Outline the practical implications of the data for the management of advanced or metastatic UC in Canadian clinical practice; and Formulate strategies to monitor for, mitigate, and manage dermatologic side effects associated with these combination therapies.